Newsroom

WPC Dubai 2023 fondation msf
Vidéos
Programme 3D

The MSF Foundation 3D program at the WPC World Physiotherapy Congress in Dubai

IrakExploEn_une
Vidéos
Programme 3D

The MSF Foundation is exploring patient follow-up possibilities in Baghdad and northern Iraq

Articles
Programme 3D

“I have huge respect for our teams in the field who face so many difficulties and danger”, says 3D programm physiotherapist Elise Tauveron on her return from Haiti.

In early 2022, the MSF Foundation launched a research study on its 3D compression mask programme for patients with severe burns in Haiti’s capital Port-au-Prince. Elise Tauveron, who has just spent a month with the teams in Haiti, talks about the launch and significance of the study. In early 2022, the MSF Foundation launched a research study on its 3D compression mask programme for patients with severe burns in Haiti’s capital Port-au-Prince. Elise Tauveron, who has just spent a month with the teams in Haiti, talks about the launch and significance of the study.

Read more
Événements
Programme 3D

Meet the MSF Foundation at the Nancy burns congress from June 8 to 10

The MSF Foundation will be present at the 41st Congress of the Société Francophone de Brûlologie at the Centre Prouvé in Nancy to talk about the 3D Program.

Read more
Masques Compressifs Haiti. Tabarre
Articles
Programme 3D

In Haiti, the MSF Foundation launches a research study on compression masks, the first of its kind in the medical world

Read more

Headline

Antibiogo 3
Articles
Antibiogo

Antibiogo ISO 13485 Certified, a First for a Humanitarian Project

In 2025, the Antibiogo application is seeing wide deployment, extending beyond MSF field operations. After being adopted by all MSF laboratories in 2024, the tool has also been integrated by local health authorities in several countries: Burkina Faso, Comoros, Guinea, Liberia, Mali, Central African Republic, Democratic Republic of the Congo, and Benin. This expansion marks a new era for Antibiogo: scaling up.

At the same time, the project team continued efforts to reach the highest level of quality standards, culminating in obtaining ISO 13485 certification. This unprecedented level of requirement for an NGO project reflects the excellence of the management practices implemented for this medical device project, for which MSF Foundation is the legal manufacturer.

Read more

MSF Foundation in Video

More articles

News

More articles

Publications

  • Publications
    Étude Fièvre Jaune

    Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in children (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial

    Read more
  • Publications
    Étude Fièvre Jaune

    Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial

    Read more
More articles

Press Review

More articles
No news for now.